Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer (NK) cell activating receptor pathways and downstream cytotoxic effectors represent the integrated molecular system through which NK cells identify and eliminate target cells, such as those that are virally infected or malignant. This system relies on a diverse array of activating receptors, including NKG2D, natural cytotoxicity receptors (NKp30, NKp44, NKp46), and CD16 (FcγRIIIa), which recognize stress-induced ligands or antibody-coated cells [UniProt; Vivier et al., 2011]. Upon activation, these receptors initiate signaling cascades that lead to the release of cytotoxic granules containing perforin and granzymes, which cooperatively induce apoptosis in the target cell [PubMed: 21508924]. Additionally, NK cells utilize death receptor ligands like FasL and TRAIL and secrete pro-inflammatory cytokines such as IFN-γ to enhance the immune response [Shimasaki et al., 2020]. Therapeutic modulation of these pathways is a cornerstone of modern oncology, utilizing monoclonal antibodies to drive antibody-dependent cellular cytotoxicity (ADCC) and developing next-generation CAR-NK cell therapies to harness these potent effector mechanisms against solid and hematological tumors [Nature Reviews Drug Discovery, 2020]. Safety considerations for these therapies include cytokine release syndrome and potential on-target off-tumor effects, though NK cells generally exhibit a more favorable safety profile than T-cell-based therapies [PubMed: 31092554].
The mechanism involves the engagement of activating receptors (e.g., NKG2D, CD16) by their respective ligands, leading to the phosphorylation of ITAM or YINM motifs on adapter proteins. This triggers downstream signaling through PI3K, PLCγ, and MAPK pathways, resulting in the mobilization of the microtubule-organizing center (MTOC) and the exocytosis of cytotoxic granules containing perforin and granzymes into the immunological synapse. Additionally, NK cells can induce apoptosis via Fas/FasL and TRAIL/TRAIL-R interactions [Vivier et al., 2011; Shimasaki et al., 2020].
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural killer cell activating receptor pathways and downstream cytotoxic effectors (NK cell activation pathways).